(Q50972710)

26 March 2018

title

Myeloid TGF-β signaling contributes to colitis-associated tumorigenesis in mice. (English)

1 reference

26 March 2018

author name string

Jingyi Li

1

1 reference

26 March 2018

Yun Liu

2

1 reference

26 March 2018

Boshi Wang

3

1 reference

26 March 2018

Yingqian Xu

4

1 reference

26 March 2018

Aihui Ma

5

1 reference

26 March 2018

Feng Zhang

6

1 reference

26 March 2018

Chao Ge

7

1 reference

26 March 2018

Zhaojuan Yang

8

1 reference

26 March 2018

Jinjun Li

9

1 reference

26 March 2018

Yongzhong Liu

10

1 reference

26 March 2018

language of work or name

English

0 references

publication date

21 May 2013

1 reference

26 March 2018

published in

Carcinogenesis

1 reference

26 March 2018

volume

34

1 reference

26 March 2018

issue

9

1 reference

26 March 2018

page(s)

2099-2108

1 reference

26 March 2018

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

NF-kappaB: linking inflammation and immunity to cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Genetic profiling of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Smad4 signalling in T cells is required for suppression of gastrointestinal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Distinct effects of p38alpha deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

TGFbeta1, a "Jack of all trades": the link with pro-inflammatory IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Conditional inactivation of the TGF-beta type II receptor using Cre:Lox

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Metabolic control of the Treg/Th17 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

21 January 2018

Fibronectin at a glance

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

Inflammation and immune surveillance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT172

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGT172

1 reference

26 March 2018

1 reference

26 March 2018